These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 498090)

  • 1. Specific inhibitors directed at the individual components of ribonucleotide reductase as an approach to combination chemotherapy.
    Cory JG; Fleischer AE
    Cancer Res; 1979 Nov; 39(11):4600-4. PubMed ID: 498090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of ribonucleotide reductase activity and nucleic acid synthesis in tumor cells by the dialdehyde derivatives of inosine (NSC 118994) and inosinic acid.
    Cory JG; Mansell MM; Whitford TW
    Cancer Res; 1976 Sep; 36(9 pt.1):3166-70. PubMed ID: 987850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on mammalian ribonucleotide reductase inhibition by pyridoxal phosphate and the dialdehyde derivatives of adenosine, adenosine 5'-monophosphate, and adenosine 5'-triphosphate.
    Cory JG; Mansell MM
    Cancer Res; 1975 Feb; 35(2):390-6. PubMed ID: 1109803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of mouse leukemia L1210 cells resistant to the ribonucleotide reductase inhibitor 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone.
    Cory AH; Sato A; Thompson DP; Cory JG
    Oncol Res; 1996; 8(10-11):449-56. PubMed ID: 9114437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of combinations of drugs that inhibit Ehrlich tumor cell ribonucleotide reductase.
    Sato A; Cory JG
    Cancer Res; 1981 May; 41(5):1637-41. PubMed ID: 6783298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver microsomal inactivation of 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone as an inhibitor of ribonucleotide reductase.
    Williams MT; Simonet L; Cory AH; Cory JG
    Cancer Res; 1988 Nov; 48(22):6375-8. PubMed ID: 3052801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reconstitution of the ribonucleotide reductase enzyme from Ehrlich tumor cells.
    Cory JG; Fleischer AE; Munro JB
    J Biol Chem; 1978 May; 253(9):2898-901. PubMed ID: 565357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-resistance patterns in hydroxyurea-resistant leukemia L1210 cells.
    Carter GL; Cory JG
    Cancer Res; 1988 Oct; 48(20):5796-9. PubMed ID: 2844392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mode of inhibition of tumor cell ribonucleotide reductase by 2,3-dihydro-1H-pyrazolo[2,3-a]imidazole (NSC 51143).
    Cory JG; Fleischer AE
    Cancer Res; 1980 Nov; 40(11):3891-4. PubMed ID: 6781737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpes simplex virus ribonucleotide reductase induced in infected BHK-21/C13 cells: biochemical evidence for the existence of two non-identical subunits, H1 and H2.
    Cohen EA; Charron J; Perret J; Langelier Y
    J Gen Virol; 1985 Apr; 66 ( Pt 4)():733-45. PubMed ID: 2984316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukemia L1210 cell lines resistant to ribonucleotide reductase inhibitors.
    Cory JG; Carter GL
    Cancer Res; 1988 Feb; 48(4):839-43. PubMed ID: 3276399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of action of inosine dialdehyde (NSC 118994) in the inhibition of proliferation of tumor cells in culture.
    Plagemann PG; Graff JC; Behrens M
    Cancer Res; 1977 Jul; 37(7 Pt 1):2188-95. PubMed ID: 193637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpes simplex type 1 ribonucleotide reductase. Mechanism studies with inhibitors.
    Spector T; Jones TE
    J Biol Chem; 1985 Jul; 260(15):8694-7. PubMed ID: 2991215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dialdehyde derivative of 5'-deoxyinosine as a more potent analog of the dialdehyde derivative of inosine (NSC 118994).
    Cory JG; Parker SH
    Biochem Pharmacol; 1979 Mar; 28(6):867-71. PubMed ID: 454484
    [No Abstract]   [Full Text] [Related]  

  • 15. Substituted 2-acylpyridine-alpha-(N)-hetarylhydrazones as inhibitors of ribonucleotide reductase activity and L1210 cell growth.
    Cory JG; Downes DL; Cory AH; Schaper KJ; Seydel JK
    Anticancer Res; 1994; 14(3A):875-9. PubMed ID: 8074487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schedule-dependency assessments of ribonucleoside diphosphate reductase inhibitors when used in combination with platinum compounds plus cyclophosphamide in the treatment of advanced L1210 leukemia.
    Gale GR; Atkins LM; Meischen SJ; Schwartz P
    Cancer Treat Rep; 1979 Mar; 63(3):449-56. PubMed ID: 427825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the ferrous chelate of 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone (MAIQ-1) on the kinetics of reduction of CDP by ribonucleotide reductase of the Novikoff tumor.
    Preidecker PJ; Agrawal KC; Sartorelli AC; Moore EC
    Mol Pharmacol; 1980 Nov; 18(3):507-12. PubMed ID: 7007866
    [No Abstract]   [Full Text] [Related]  

  • 18. Altered efflux properties of mouse leukemia L1210 cells resistant to 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone.
    Cory JG; Cory AH; Lorico A; Rappa G; Sartorelli AC
    Anticancer Res; 1997; 17(5A):3185-93. PubMed ID: 9413147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noncoordinate changes in the components of ribonucleotide reductase in mammalian cells.
    Cory JG; Fleischer AE
    J Biol Chem; 1982 Feb; 257(3):1263-6. PubMed ID: 7035447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative cytotoxic and biochemical effects of ligands and metal complexes of alpha-N-heterocyclic carboxaldehyde thiosemicarbazones.
    Saryan LA; Ankel E; Krishnamurti C; Petering DH; Elford H
    J Med Chem; 1979 Oct; 22(10):1218-21. PubMed ID: 513069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.